Vulvar Carcinoma — Trials

Vulvar Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

52 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 31%
Top sponsor: Christian Hinrichs
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03221400	PEN-866 in Patients With Advanced Solid Malignancies	unknown	Phase 1 / Phase 2	340	Tarveda TherapeuticsINDUSTRY	1	Feb 17, 2022	clinicaltrials
NCT01595061	Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva	unknown	Phase 2	57	Gynecologic Oncology GroupNETWORK	1	Dec 29, 2021	clinicaltrials